- Filed
- May 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 8, 2024 | 2.55M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 2.58M sh |
| Shares Diluted restated | Q1 2024 · Mar 31, 2023 | 3.02M sh |
| Stock Repurchased | Q1 2024 · Mar 31, 2024 | $0 |
| Stock Repurchased | Q1 2024 · Mar 31, 2023 | $1.5M |
| Capex | Q1 2024 · Mar 31, 2024 | $0 |
| Capex | Q1 2024 · Mar 31, 2023 | $31K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$2.05M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$6.94M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $6.65M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $8.71M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $11.84M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $3.26M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$125.84M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | −$94.22M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | −$89.89M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $17.13M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $7.17M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $20.39M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $25.54M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | $49.98 |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$0.99 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | $50.54 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$0.99 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $341K |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $934K |
| Rd Expense | Q1 2024 · Mar 31, 2024 | $1.93M |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $0 |
| Net Income | Q1 2024 · Mar 31, 2024 | −$3.11M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$2.99M |